Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA.

Access publication

Citation: Hsu HE, Rydzak CE, Cotich KL, Wang B, Sax PE, Losina E, Freedberg KA, Goldie SJ, Lu Z, Walensky RP; CEPAC Investigators. Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA. HIV Med. 2011 Feb.

Authors